カテゴリー： 世界, 医療/バイオ, Market Research Future

幹細胞製造の世界市場予測（～2030年）

【英語タイトル】Global Stem Cell Manufacturing Market Forecast to 2030

Market Research Futureが出版した調査資料（MRF23JNE027）・商品コード：MRF23JNE027
・発行会社（調査会社）：Market Research Future
・発行日：2023年6月
・ページ数：116
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（印刷不可、Online Access）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Enterprisewide Price（印刷可）USD7,250 ⇒換算￥1,102,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

マーケットリサーチフューチャー社では、世界の幹細胞製造市場が予測期間中に年平均成長率13.16％を記録すると予測しています。当レポートは、幹細胞製造の世界市場について広く調査・分析を行い、イントロダクション、調査手法、市場インサイト、市場動向、市場要因分析、用途別（研究、ターゲット同定、幹細胞治療、細胞＆組織バンキング）分析、エンドユーザー別（製薬＆バイオテクノロジー企業、病院、幹細胞バンク、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、その他地域）分析、競争状況、企業情報などの項目をまとめています。なお、参入企業情報として、Fujifilm Holdings Corporation (US)、AbbVie, Inc. (US)、Bio-Rad Laboratories, Inc. (US)、Becton、Dickinson、and Company (US)、Thermo Fisher Scientific, Inc. (US)、Lonza Group (Switzerland)、Bristol-Myers Squibb Company (US)、GlaxoSmithKline Plc (UK)、Sartorius AG (Germany)、Merck KGaA (Germany)などが含まれています。
・エグゼクティブサマリー
・イントロダクション
・調査手法
・市場動向
・市場要因分析
・世界の幹細胞製造市場規模：用途別
　 - 研究における市場規模
　 - ターゲット同定における市場規模
　 - 幹細胞治療における市場規模
　 - 細胞＆組織バンキングにおける市場規模
・世界の幹細胞製造市場規模：エンドユーザー別
　 - 製薬＆バイオテクノロジー企業における市場規模
　 - 病院における市場規模
　 - 幹細胞バンクにおける市場規模
　 - その他エンドユーザーにおける市場規模
・世界の幹細胞製造市場規模：地域別
　 - 北米の幹細胞製造市場規模
　 - ヨーロッパの幹細胞製造市場規模
　- アジア太平洋の幹細胞製造市場規模
　- その他地域の幹細胞製造市場規模
・競争状況
・企業情報

幹細胞製造の2030年までの市場予測

市場概要：
幹細胞製造市場は、図期間中に13.16%の重要な年間成長率（CAGR）に遭遇すると予測されています。幹細胞治療は、AIDS、心血管疾患、神経変性疾患、自己免疫感染症、筋疾患、創傷治癒など、すでに絶望的な多くの感染症に対する可能性の高い医薬品を提供します。幹細胞は、脊髄損傷、パーキンソン病、アルツハイマー病、その他の神経学的問題によって傷ついた神経細胞を置き換えるために利用されつつあります。また、糖尿病患者にインスリンを投与したり、傷ついた組織や臓器の回復を助けたりする際にも、緊急の役割を担っています。
人口のわずかなレベルにしか影響を与えない興味深い病気は、患者数が限られていることや、治療法の確立に多額の費用がかかることから、軽視されがちです。これらの病気には、珍しい腫瘍、遺伝性疾患、抵抗力のない熱帯感染症、退行性感染症などが含まれます。2020年2月に食品医薬品局（FDA）が配布した情報によると、珍しい病気はおよそ7,000種類あり、そのうちの一部以上が子供に影響を及ぼしています。とはいえ、これらの感染症のうち、FDAお墨付きの薬があるのはわずか5％。そのため、さまざまな感染症治療への幹細胞応用に対する意識の高まりと、珍しい病気の増加率が、市場の発展に拍車をかけています。

市場の細分化：
幹細胞製造市場のセグメント化には、幹細胞株、装置、培地、消耗品などの製品が含まれます。間葉系幹細胞（MSCs）、人工多能性幹細胞（iPSC）、胚性幹細胞（ESCs）、造血幹細胞（HSCs）、その他の幹細胞は幹細胞株のサブカテゴリーです。バイオリアクター、インキュベーター、セルソーター、その他のツールは機器の一例です。研究、標的同定、幹細胞を用いた治療、細胞や組織のバンキングなどの用途も、市場データのセグメンテーションに使用されています。世界の幹細胞市場は、エンドユーザーによって病院、製薬会社、バイオテクノロジー企業、幹細胞バンク、その他の事業体に区分されます。

地域分析：
2021年の幹細胞製造市場で最大のシェアを占めたのは北米でした。これは、悪性成長、心血管問題、神経学的問題、胃腸疾患、その他の進行中の状況を含む、恒常的な病気の一般的な増加によるものです。
ヨーロッパは、幹細胞製造市場において第2位に位置しています。その理由の大部分は、最先端の治療オフィスへのアクセス、医療サービス分野の改善に対する政府の支援、発展途上の高齢者人口、恒常的な問題や神経学的問題を含む症例数の増加によるものです。
アジア太平洋地域は、2022年から2030年にかけて幹細胞製造市場において重要な発展を遂げると考えられています。この発展には、医療制度の改善、幹細胞治療の普及、協定メーカーの存在、この地域における疾病の増加などが要因として挙げられます。現在、アジア太平洋地域では中国が最大の市場シェアを占めており、インドが最も高い発展率を示しています。

主要企業：
この市場調査における主要企業には、Fujifilm Holdings Corporation (US), AbbVie, Inc. (US), Bio-Rad Laboratories, Inc. (US), Becton, Dickinson, and Company (US), Thermo Fisher Scientific, Inc. (US), Lonza Group (Switzerland), Bristol-Myers Squibb Company (US), GlaxoSmithKline Plc (UK), Sartorius AG (Germany), Merck KGaA (Germany)などが含まれます。

新型コロナウイルスの影響：
弊社では、新型コロナウイルスのパンデミックがあらゆる分野のさまざまな業界や業種に与える影響を継続的に追跡しています。当社の調査レポートでは、新型コロナウイルスの産業への影響による減少や上昇を理解するのに役立ちます。また、貴社が関心をお持ちの市場の需要と供給のギャップを特定するのにも役立ちます。さらに、このレポートは、分析、改正された政府規制、その他多くの有用な洞察を支援します。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY

2.2 RESEARCH OBJECTIVE

2.3 MARKET STRUCTURE

2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 GROWING AWARENESS REGARDING THE USAGE OF STEM CELLS FOR TREATING VARIOUS DISEASES

4.2.2 INCREASING PREVALENCE OF RARE DISEASES

4.2.3 TECHNOLOGICAL ADVANCEMENTS IN STEM CELL MANUFACTURING

4.3 RESTRAINTS

4.3.1 RISKS ASSOCIATED WITH UNPROVEN STEM CELL TREATMENTS

4.3.2 HIGHER OPERATIONAL COSTS ASSOCIATED WITH STEM CELL MANUFACTURING AND BANKING

4.4 OPPORTUNITIES

4.4.1 INCREASING PUBLIC AND PRIVATE FUNDING FOR STEM CELL-BASED RESEARCH

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D AND DESIGNING

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION & SALES

5.1.4 POST-SALES REVIEW

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 BARGAINING POWER OF BUYERS

5.2.4 INTENSITY OF RIVALRY

5.2.5 THREAT OF SUBSTITUTES

5.3 IMPACT OF COVID-19

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON PRODUCTION

5.3.3 IMPACT ON DEMAND-SUPPLY GAP ANALYSIS

5.3.4 IMPACT ON R&D

6 GLOBAL STEM CELL MANUFACTURING MARKET, BY PRODUCT

6.1 OVERVIEW

6.2 STEM CELL LINES

6.3 INSTRUMENTS

6.4 CULTURE MEDIA

6.5 CONSUMABLES

7 GLOBAL STEM CELL MANUFACTURING MARKET, BY APPLICATION

7.1 OVERVIEW

7.2 RESEARCH

7.3 TARGET IDENTIFICATION

7.4 STEM CELL-BASED THERAPY

7.5 CELL AND TISSUE BANKING

8 GLOBAL STEM CELL MANUFACTURING MARKET, BY END USER

8.1 OVERVIEW

8.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

8.3 HOSPITALS

8.4 STEM CELL BANKS

8.5 OTHERS

9 GLOBAL STEM CELL MANUFACTURING MARKET, BY REGION

9.1 OVERVIEW

9.2 NORTH AMERICA

9.2.1 US

9.2.2 CANADA

9.3 EUROPE

9.3.1 GERMANY

9.3.2 FRANCE

9.3.3 UK

9.3.4 ITALY

9.3.5 SPAIN

9.3.6 REST OF EUROPE

9.4 ASIA-PACIFIC

9.4.1 CHINA

9.4.2 INDIA

9.4.3 JAPAN

9.4.4 SOUTH KOREA

9.4.5 AUSTRALIA

9.4.6 REST OF ASIA-PACIFIC

9.5 REST OF THE WORLD

9.5.1 MIDDLE EAST

9.5.2 AFRICA

9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW

10.2 COMPETITIVE BENCHMARKING

10.3 MAJOR GROWTH STRATEGY IN STEM CELL MANUFACTURING MARKET

10.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN STEM CELL MANUFACTURING MARKET

10.5 KEY DEVELOPMENT ANALYSIS

10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

10.6.1 PRODUCT APPROVALS AND PRODUCT LAUNCHES

10.6.2 PARTNERSHIP/COLLABORATION

10.6.3 BUSINESS EXPANSIONS/AGREEMENTS

10.6.4 MERGERS & ACQUISITIONS

11 COMPANY PROFILES

11.1 ABBVIE, INC.

11.1.1 COMPANY OVERVIEW

11.1.2 FINANCIAL OVERVIEW

11.1.3 PRODUCTS OFFERED

11.1.4 KEY DEVELOPMENTS

11.1.5 SWOT ANALYSIS

11.1.6 KEY STRATEGIES

11.2 BIO-RAD LABORATORIES, INC.

11.2.1 COMPANY OVERVIEW

11.2.2 FINANCIAL OVERVIEW

11.2.3 PRODUCTS OFFERED

11.2.4 KEY DEVELOPMENTS

11.2.5 SWOT ANALYSIS

11.2.6 KEY STRATEGIES

11.3 FUJIFILM HOLDINGS CORPORATION (FUJIFILM CELLULAR DYNAMICS, INC.)

11.3.1 COMPANY OVERVIEW

11.3.2 FINANCIAL OVERVIEW

11.3.3 PRODUCTS OFFERED

11.3.4 KEY DEVELOPMENTS

11.3.5 KEY STRATEGIES

11.4 BECTON DICKINSON AND COMPANY

11.4.1 COMPANY OVERVIEW

11.4.2 FINANCIAL ANALYSIS

11.4.3 PRODUCTS OFFERED

11.4.4 KEY DEVELOPMENTS

11.4.5 KEY STRATEGIES

11.5 THERMO FISHER SCIENTIFIC INC.

11.5.1 COMPANY OVERVIEW

11.5.2 FINANCIAL ANALYSIS

11.5.3 PRODUCTS OFFERED

11.5.4 KEY DEVELOPMENTS

11.5.5 SWOT ANALYSIS

11.5.6 KEY STRATEGIES

11.6 LONZA GROUP

11.6.1 COMPANY OVERVIEW

11.6.2 FINANCIAL ANALYSIS

11.6.3 PRODUCTS OFFERED

11.6.4 KEY DEVELOPMENTS

11.6.5 KEY STRATEGIES

11.7 BRISTOL-MYERS SQUIBB COMPANY

11.7.1 COMPANY OVERVIEW

11.7.2 FINANCIAL OVERVIEW

11.7.3 PRODUCTS OFFERED

11.7.4 KEY DEVELOPMENTS

11.7.5 KEY STRATEGIES

11.8 GLAXOSMITHKLINE PLC

11.8.1 COMPANY OVERVIEW

11.8.2 FINANCIAL OVERVIEW

11.8.3 PRODUCTS OFFERED

11.8.4 KEY DEVELOPMENTS

11.8.5 SWOT ANALYSIS

11.8.6 KEY STRATEGIES

11.9 SARTORIUS AG

11.9.1 COMPANY OVERVIEW

11.9.2 FINANCIAL OVERVIEW

11.9.3 PRODUCTS OFFERED

11.9.4 KEY DEVELOPMENTS

11.9.5 KEY STRATEGIES

11.10 MERCK KGAA

11.10.1 COMPANY OVERVIEW

11.10.2 FINANCIAL OVERVIEW

11.10.3 PRODUCTS OFFERED

11.10.4 KEY DEVELOPMENTS

11.10.5 KEY STRATEGIES

11.11 TAKEDA PHARMACEUTICAL COMPANY LIMITED

11.11.1 COMPANY OVERVIEW

11.11.2 FINANCIAL OVERVIEW

11.11.3 PRODUCTS OFFERED

11.11.4 KEY DEVELOPMENTS

11.11.5 SWOT ANALYSIS

11.11.6 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES

12.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 4 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 5 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 6 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY REGION, 2018–2027 (USD MILLION)

TABLE 7 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 8 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR CULTURE MEDIA, BY REGION, 2018–2027 (USD MILLION)

TABLE 9 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR CONSUMABLES, BY REGION, 2018–2027 (USD MILLION)

TABLE 10 GLOBAL: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 11 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR RESEARCH, BY REGION, 2018–2027 (USD MILLION)

TABLE 12 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR TARGET IDENTIFICATION, BY REGION, 2018–2027 (USD MILLION)

TABLE 13 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY REGION, 2018–2027 (USD MILLION)

TABLE 14 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 15 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR CELL AND TISSUE BANKING, BY REGION, 2018–2027 (USD MILLION)

TABLE 16 GLOBAL: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 17 GLOBAL: STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2027 (USD MILLION)

TABLE 18 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR HOSPITALS, BY REGION, 2018–2027 (USD MILLION)

TABLE 19 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR STEM CELL BANKS, BY REGION, 2018–2027 (USD MILLION)

TABLE 20 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 21 GLOBAL: STEM CELL MANUFACTURING MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 22 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 23 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 24 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES BY TYPE, 2018–2027 (USD MILLION)

TABLE 25 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS BY TYPE, 2018–2027 (USD MILLION)

TABLE 26 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 27 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR STEM CELL-BASED THERAPY BY TYPE, 2018–2027 (USD MILLION)

TABLE 28 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 29 US: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 30 US: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES BY TYPE, 2018–2027 (USD MILLION)

TABLE 31 US: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS BY TYPE, 2018–2027 (USD MILLION)

TABLE 32 US: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 33 US: STEM CELL MANUFACTURING MARKET FOR STEM CELL-BASED THERAPY BY TYPE, 2018–2027 (USD MILLION)

TABLE 34 US: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 35 CANADA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 36 CANADA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES BY TYPE, 2018–2027 (USD MILLION)

TABLE 37 CANADA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS BY TYPE, 2018–2027 (USD MILLION)

TABLE 38 CANADA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 39 CANADA: STEM CELL MANUFACTURING MARKET FOR STEM CELL-BASED THERAPY BY TYPE, 2018–2027 (USD MILLION)

TABLE 40 CANADA: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 41 EUROPE: STEM CELL MANUFACTURING MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 42 EUROPE: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 43 EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES BY TYPE, 2018–2027 (USD MILLION)

TABLE 44 EUROPE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS BY TYPE, 2018–2027 (USD MILLION)

TABLE 45 EUROPE: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 46 EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL-BASED THERAPY BY TYPE, 2018–2027 (USD MILLION)

TABLE 47 EUROPE: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 48 GERMANY: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 49 GERMANY: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES BY TYPE, 2018–2027 (USD MILLION)

TABLE 50 GERMANY: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS BY TYPE, 2018–2027 (USD MILLION)

TABLE 51 GERMANY: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 52 GERMANY: STEM CELL MANUFACTURING MARKET FOR STEM CELL-BASED THERAPY BY TYPE, 2018–2027 (USD MILLION)

TABLE 53 GERMANY: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 54 FRANCE: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 55 FRANCE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES BY TYPE, 2018–2027 (USD MILLION)

TABLE 56 FRANCE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS BY TYPE, 2018–2027 (USD MILLION)

TABLE 57 FRANCE: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 58 FRANCE: STEM CELL MANUFACTURING MARKET FOR STEM CELL-BASED THERAPY BY TYPE, 2018–2027 (USD MILLION)

TABLE 59 FRANCE: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 60 UK: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 61 UK: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES BY TYPE, 2018–2027 (USD MILLION)

TABLE 62 UK: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS BY TYPE, 2018–2027 (USD MILLION)

TABLE 63 UK: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 64 UK: STEM CELL MANUFACTURING MARKET FOR STEM CELL-BASED THERAPY BY TYPE, 2018–2027 (USD MILLION)

TABLE 65 UK: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 66 ITALY: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 67 ITALY: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES BY TYPE, 2018–2027 (USD MILLION)

TABLE 68 ITALY: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS BY TYPE, 2018–2027 (USD MILLION)

TABLE 69 ITALY: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 70 ITALY: STEM CELL MANUFACTURING MARKET FOR STEM CELL-BASED THERAPY BY TYPE, 2018–2027 (USD MILLION)

TABLE 71 ITALY: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 72 SPAIN: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 73 SPAIN: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES BY TYPE, 2018–2027 (USD MILLION)

TABLE 74 SPAIN: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS BY TYPE, 2018–2027 (USD MILLION)

TABLE 75 SPAIN: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 76 SPAIN: STEM CELL MANUFACTURING MARKET FOR STEM CELL-BASED THERAPY BY TYPE, 2018–2027 (USD MILLION)

TABLE 77 SPAIN: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 78 REST OF EUROPE: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 79 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES BY TYPE, 2018–2027 (USD MILLION)

TABLE 80 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS BY TYPE, 2018–2027 (USD MILLION)

TABLE 81 REST OF EUROPE: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 82 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL-BASED THERAPY BY TYPE, 2018–2027 (USD MILLION)

TABLE 83 REST OF EUROPE: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 84 ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 85 ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 86 ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 87 ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 88 ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 89 ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 90 ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 91 CHINA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 92 CHINA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 93 CHINA: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 94 CHINA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 95 CHINA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 96 CHINA: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 97 INDIA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 98 INDIA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 99 INDIA: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 100 INDIA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 101 INDIA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 102 INDIA: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 103 JAPAN: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 104 JAPAN: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 105 JAPAN: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 106 JAPAN: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 107 JAPAN: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 108 JAPAN: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 109 SOUTH KOREA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 110 SOUTH KOREA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 111 SOUTH KOREA: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 112 SOUTH KOREA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 113 SOUTH KOREA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 114 SOUTH KOREA: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 115 AUSTRALIA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 116 AUSTRALIA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 117 AUSTRALIA: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 118 AUSTRALIA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 119 AUSTRALIA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 120 AUSTRALIA: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 121 REST OF ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 122 REST OF ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 123 REST OF ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 124 REST OF ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 125 REST OF ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 126 REST OF ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 127 REST OF THE WORLD: STEM CELL MANUFACTURING MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 128 REST OF THE WORLD: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 129 REST OF THE WORLD: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 130 REST OF THE WORLD: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 131 REST OF THE WORLD: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 132 REST OF THE WORLD: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 133 REST OF THE WORLD: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 134 MIDDLE EAST: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 135 MIDDLE EAST: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 136 MIDDLE EAST: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 137 MIDDLE EAST: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 138 MIDDLE EAST: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 139 MIDDLE EAST: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 140 AFRICA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 141 AFRICA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 142 AFRICA: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 143 AFRICA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 144 AFRICA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 145 AFRICA: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 146 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 147 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 148 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 149 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 150 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 151 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 152 MAJOR MANUFACTURERS IN STEM CELL MANUFACTURING MARKET

TABLE 153 MOST ACTIVE PLAYER IN STEM CELL MANUFACTURING MARKET

TABLE 154 PRODUCT APPROVALS AND PRODUCT LAUNCHES

TABLE 155 PARTNERSHIP/COLLABORATION

TABLE 156 BUSINESS EXPANSIONS/ AGREEMENTS

TABLE 157 MERGERS & ACQUISITIONS

TABLE 158 ABBVIE, INC.: PRODUCTS OFFERED

TABLE 159 ABBVIE, INC.: KEY DEVELOPMENTS

TABLE 160 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED

TABLE 161 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED

TABLE 162 FUJIFILM HOLDINGS CORPORATION: KEY DEVELOPMENTS

TABLE 163 BECTON DICKINSON AND COMPANY: PRODUCTS OFFERED

TABLE 164 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED

TABLE 165 THERMO FISHER SCIENTIFIC INC.: KEY DEVELOPMENTS

TABLE 166 LONZA GROUP: PRODUCTS OFFERED

TABLE 167 LONZA GROUP: KEY DEVELOPMENTS

TABLE 168 BRISTOL-MYERS SQUIBB COMPANY: PRODUCTS OFFERED

TABLE 169 BRISTOL-MYERS SQUIBB COMPANY: KEY DEVELOPMENTS

TABLE 170 GLAXOSMITH KLINE PLC: PRODUCTS OFFERED

TABLE 171 GLAXOSMITHKLINE PLC: KEY DEVELOPMENTS

TABLE 172 SARTORIUS AG: PRODUCTS OFFERED

TABLE 173 SARTORIUS AG: KEY DEVELOPMENTS

TABLE 174 MERCK KGAA: PRODUCTS OFFERED

TABLE 175 TAKEDA PHARMACEUTICAL COMPANY LIMITED: PRODUCTS OFFERED

TABLE 176 TAKEDA PHARMACEUTICAL COMPANY LIMITED: KEY DEVELOPMENTS



★調査レポート[幹細胞製造の世界市場予測（～2030年）] (コード：MRF23JNE027)販売に関する免責事項を必ずご確認ください。
★調査レポート[幹細胞製造の世界市場予測（～2030年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の食道扁平上皮がん市場（〜2030年）
  • 世界の羊膜市場（〜2030年）
  • 世界の造血幹細胞移植（HSCT）市場（～2030年）：移植種類別（同種移植、自家移植、その他）、適応疾患別（リンパ増殖性疾患、非悪性疾患、白血病、その他）、用途別（骨髄移植（BMT）、末梢血幹細胞移植（PBSCT）、臍帯血移植（CBT）、その他）、エンドユーザー別、地域別
  • 自動細胞計数のグローバル市場（2023年-2030年）：装置、消耗品＆付属品
  • 世界のヒト胚性幹細胞（ES細胞）市場（～2030年）：種類別（全能性幹細胞、多能性幹細胞、多能性幹細胞、オリゴ多能性幹細胞、単能性幹細胞、その他）、供給源別、用途別、地域別
  • 世界のダーカム病市場（〜2030年）
  • 世界の骨生検市場（〜2030年）
  • 世界の水中ロボット市場（〜2030年）
  • 血栓治療の世界市場予測（～2030年）
  • 世界のHERGスクリーニング市場（〜2030年）

    • ◆H&Iグローバルリサーチのお客様（例）◆